As the 68th session of the United Nations (UN) Commission on Narcotic Drugs approaches in March 2025, the international debate over the regulation of hexahydrocannabinol (HHC) continues to gain momentum ...
It remains unclear where the hemp and CBD investment centre for Asia will develop. History and existing infrastructure would point to Hong Kong, but development there has stalled – and there are other contenders ...
Singaporean authorities do not believe there is sufficient evidence supporting the efficacy of “raw” cannabis, considering the plant and its derivatives to be a dangerous drug with few medical benefits ...
Start your FREE trial
Get 7 days of access to industry updates through our news analysis and regulatory alerts